Overactive Bladder - Results from #70

"There is a lot of shame that comes with this": A qualitative study of patient experiences of isolation, embarrassment, and stigma associated with overactive bladder. July 25, 2024

The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. July 19, 2024

The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study. July 19, 2024

Prevalence and trends in overactive bladder among men in the United States, 2005-2020. July 19, 2024

Menopausal stages and overactive bladder symptoms in middle-aged women: A cross-sectional study. July 12, 2024

Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. July 12, 2024

Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL). July 7, 2024

The association between wet overactive bladder and consumption of tea, coffee, and caffeine: Results from 2005-2018 National Health and Nutrition Examination Survey. July 7, 2024

Relationship Between Overactive Bladder and Bone Fracture Risk in Female Patients. July 7, 2024

Botulinum toxin A for idiopathic overactive bladder in women. June 28, 2024

Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder. June 28, 2024

The exposure to volatile organic compounds associate positively with overactive bladder risk in U.S. adults: a cross-sectional study of 2007-2020 NHANES. June 28, 2024

Overactive bladder and cognitive impairment in middle-aged women: A cross-sectional study. June 21, 2024

Association between body roundness index and overactive bladder: results from the NHANES 2005-2018. June 21, 2024

Language, cultural adaptation and validation of the OABSS (Overactive Bladder Symptom Score) questionnaire in patients with overactive bladder. June 14, 2024

Topical estrogen therapy ameliorates bladder estrogen receptor β expression in female patients with overactive bladder. June 14, 2024

Association between life's essential 8 and overactive bladder. June 14, 2024

Prospective follow-up of overactive bladder symptoms in patients with prior SARS-CoV-2 infection. June 9, 2024

Intradetrusor Versus Suburothelial Onabotulinum Toxin A in Adults with Neurogenic and Non-neurogenic Overactive Bladder Syndrome: A Meta-Analysis. June 9, 2024

Increased prevalence of metabolic syndrome in female patients with overactive bladder: A population-based study. June 9, 2024

Page 4 of 122